CIM
BIIB icon

CenturyLink Investment Management’s Biogen BIIB Stock Holding History

CenturyLink Investment Management’s Portfolio BIIB Stock Details BIIB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q2 		– Sell
-3,941
Closed -$1.25M – 29
2020
Q1 		$1.25M Hold
3,941
– – 0.79% 31
2019
Q4 		$1.17M Sell
3,941
-614
-13% -$170K 0.56% 61
2019
Q3 		$1.06M Sell
4,555
-771
-14% -$180K 0.48% 101
2019
Q2 		$1.25M Hold
5,326
– – 0.49% 103
2019
Q1 		$1.26M Sell
5,326
-106
-2% -$33.4K 0.51% 85
2018
Q4 		$1.64M Sell
5,432
-496
-8% -$158K 0.76% 26
2018
Q3 		$2.09M Sell
5,928
-709
-11% -$244K 0.75% 26
2018
Q2 		$1.93M Buy
6,637
+1,563
+31% +$439K 0.74% 27
2018
Q1 		$1.39M Hold
5,074
– – 0.5% 87
2017
Q4 		$1.62M Sell
5,074
-546
-10% -$175K 0.57% 60
2017
Q3 		$1.76M Hold
5,620
– – 0.57% 61
2017
Q2 		$1.52M Sell
5,620
-390
-6% -$103K 0.51% 80
2017
Q1 		$1.64M Hold
6,010
– – 0.53% 78
2016
Q4 		$1.7M Buy
6,010
+4,791
+393% +$1.42M 0.58% 53
2016
Q3 		$382K Sell
1,219
-706
-37% -$209K 0.13% 174
2016
Q2 		$466K Buy
1,925
+1,294
+205% +$341K 0.17% 163
2016
Q1 		$164K Sell
631
-263
-29% -$69.5K 0.06% 209
2015
Q4 		$274K Sell
894
-3,054
-77% -$878K 0.1% 209
2015
Q3 		$1.15M Buy
3,948
+155
+4% +$51.2K 0.37% 99
2015
Q2 		$1.53M Buy
3,793
+1,784
+89% +$716K 0.51% 67
2015
Q1 		$848K Sell
2,009
-52
-3% -$20.5K 0.28% 131
2014
Q4 		$700K Sell
2,061
-3,576
-63% -$1.16M 0.21% 157
2014
Q3 		$1.86M Sell
5,637
-567
-9% -$187K 0.63% 42
2014
Q2 		$1.96M Buy
6,204
+813
+15% +$245K 0.61% 39
2014
Q1 		$1.65M Sell
5,391
-922
-15% -$293K 0.53% 58
2013
Q4 		$1.77M Sell
6,313
-1,189
-16% -$308K 0.54% 67
2013
Q3 		$1.81M Sell
7,502
-5,543
-42% -$1.24M 0.55% 60
2013
Q2 		$2.81M Buy
+13,045
New +$2.79M 0.81% 20

Other funds holding BIIB

Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
ClearBridge Investments
ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

CenturyLink Investment Management's BIIB Position: Q2 2020 in Review

CenturyLink Investment Management sold out of Biogen (BIIB) in Q2 2020, closing a stake of 3,941 shares — an estimated $1.25M sold.

CenturyLink Investment Management first reported a position in BIIB in Q2 2013 and held it in 28 quarters. The position peaked at $2.81M in Q2 2013. 1,059 funds tracked by Wall St. Rank hold BIIB as of Q2 2020.

  • CenturyLink Investment Management reported no remaining Biogen position as of Q2 2020 after selling out during the quarter.
  • CenturyLink Investment Management sold 3,941 Biogen shares in Q2 2020, an estimated $1.25M.
  • CenturyLink Investment Management first reported a position in Biogen in Q2 2013 and held it in 28 quarters.
  • CenturyLink Investment Management's Biogen position peaked at $2.81M in Q2 2013.
  • 1,059 funds tracked by Wall St. Rank held Biogen as of Q2 2020.

Based on CenturyLink Investment Management's 13F filing for Q2 2020, filed 9 Jul 2020.